Zdrowie i gospodarka · 20/12/2016

FDA Issues Regulations for Postmarketing Safety Reporting of Combination Products

The US Food and Drug Administration (FDA) has issued a final rule requiring the reporting of postmarketing safety data for combination products, which include drugs, devices, and biological products used together, and have received FDA marketing approval.